Site içinde arama yapın | SocioMint

Rutuja Bhosale bir ses eklendi Other
2026-08-12 07:32:00 -

Dopamine Agonist Market Analysis: Investment, Innovation, and Growth Opportunities Through 2034
The Global Dopamine Agonist Market is experiencing steady growth, driven by the rising prevalence of neurological and hormonal disorders and the increasing demand for effective pharmacological treatments. Valued at approximately USD 1.6 billion in 2025, the market is projected to reach USD 2.5 billion by 2033, expanding at a CAGR of 6.1% during the forecast...

0 Yorumlar 0 hisse senetleri 29 Views 0 önizleme

Please log in to like, share and comment!
Surbhi Verma bir ses eklendi Health
2026-07-02 10:32:51 -

Prolactinoma Market: How Is Cabergoline Resistance and Dopamine Agonist-Intolerant Patient Management Creating New Therapeutic Opportunities?
Prolactinoma — the benign pituitary adenoma arising from lactotroph cells causing hyperprolactinemia, galactorrhea, amenorrhea, infertility, and mass effect symptoms including headache and visual field defects — represents the most common functioning pituitary tumor requiring chronic pharmacological management, with the Prolactinoma Market reflecting dopamine agonist therapy and...

0 Yorumlar 0 hisse senetleri 621 Views 0 önizleme

Please log in to like, share and comment!

SocioMint https://sociomint.com